Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 144

Results For "Facility"

1724 News Found

Glenmark Pharma gets observations from USFDA for its Goa and Monroe facilities
News | May 22, 2022

Glenmark Pharma gets observations from USFDA for its Goa and Monroe facilities

A total of five observations for Goa and 17 for Monroe


SIMS Hospital conducts high-performance hip replacement surgery
Hospitals | May 21, 2022

SIMS Hospital conducts high-performance hip replacement surgery

The patient, who was previously diagnosed with osteoarthritis, was prescribed hip replacement surgery as the best and most effective solution for his condition


Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics
News | May 19, 2022

Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics

Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions for targeted radiopharmaceuticals


Piramal Pharma Solutions new API plant in Canada goes online
Biotech | May 19, 2022

Piramal Pharma Solutions new API plant in Canada goes online

It is part of the company's CAD $30 million capital investment in the Aurora, Canada site


Eight Roads announce US $ 250 million healthcare fund for India
News | May 17, 2022

Eight Roads announce US $ 250 million healthcare fund for India

This new fund is amongst the largest for the sector in India


PCI Pharma Services announces US $100 million investment in New England
Biotech | May 13, 2022

PCI Pharma Services announces US $100 million investment in New England

Capabilities include the latest in sterile lyophilization and liquid filling technology to support global pharmaceutical supply chain, keeping pace with industry trends


Aurobindo Pharma Ltd gets 6 observations from USFDA for Unit VII
News | May 11, 2022

Aurobindo Pharma Ltd gets 6 observations from USFDA for Unit VII

The unit is an oral manufacturing facility at Jedcherla, Hyderabad


Aarti Drugs Q4FY 22 consolidated revenue grew by 39 per cent YoY
News | May 10, 2022

Aarti Drugs Q4FY 22 consolidated revenue grew by 39 per cent YoY

The capex for FY22 stood at Rs 145 crore and is expected to be in the range of Rs 250-350 crore for the entire FY23 which would be funded through a mix of internal accruals and debt


Lonza, ALSA Ventures collaborate on providing manufacturing services to biotech firms
Biotech | May 10, 2022

Lonza, ALSA Ventures collaborate on providing manufacturing services to biotech firms

The new framework collaboration will support due diligence into ALSA’s potential investments, which will assist with their investment de-risking


Bora Pharmaceuticals acquires Eden Biologics CDMO assets
Biotech | May 10, 2022

Bora Pharmaceuticals acquires Eden Biologics CDMO assets

Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market